FDA approves Immulite PSA (prostate-specific antigen) assays:
This article was originally published in Clinica
Executive Summary
The US FDA has granted marketing approval for four prostate-specific antigen (PSA) assays manufactured by Diagnostic Products for use in the diagnosis of prostate cancer. They are the Immulite PSA, the Immulite 2000 PSA, the Immulite Third Generation PSA and the Immulite 2000 Third Generation PSA.